Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 25,452,185	$ 23,678,798	$ 18,795,517
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,899,851	3,533,564	3,297,289
Abandoned patents or software written off			88,796
Provision for bad debts	(614,680)	477,577	(201,949)
Deferred income tax benefit - net	(4,919,750)	(4,969,669)	(4,647,767)
Income tax receivable	(1,200,000)
Gain on acquisition			(192,999)
Compensatory element of stock issuances	0	2,397,276	$ 2,006
Stock issued for costs and expenses		$ 2,239,302
Stock option exercised		1,680	1,755
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	(4,328,239)	$ (5,899,611)	$ (3,557,507)
Notes receivable	(894,665)	11,511	28,280
Costs and estimated earnings in excess of Billings on uncompleted contracts	649,423	(736,061)	681,660
Inventories	192,882	450,038	117,549
Prepaid expenses and other current assets	(1,553)	(513,507)	72,718
Other assets	15,008	254,721	18,054
Increase (decrease) in operating liabilities, net:
Accounts payable	(122,967)	168,733	(527,957)
Other current liabilities	525,113	(3,660,895)	3,065,673
Customer advances	70,311	(410,855)	(739,074)
Billings in excess of costs and estimated earnings on uncompleted contracts		(206,623)	64,406
Other Liabilities	16,404	8,783	242,798
Due to related party medical practices		(17,498)	8,121
NET CASH PROVIDED BY OPERATING ACTIVITIES	18,739,323	16,807,264	16,617,369
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(2,777,948)	(2,851,158)	(712,216)
Cost of acquisition	(58,274)	(1,312,769)	(4,223,567)
Cost of patents	(108,829)	(155,156)	(113,072)
NET CASH USED IN INVESTING ACTIVITIES	(2,945,051)	(4,319,083)	(5,048,855)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of borrowings and capital lease obligations	(172,484)	(3,990,078)	(3,682,519)
Repayment of notes receivable from employee stockholders	7,333	7,333	7,616
Distributions to noncontrolling interests	(6,135,000)	(6,981,953)	(5,909,100)
Redemption of noncontroling Interests			(2,905,000)
Proceeds received from acquisition -net		87,829
NET CASH USED IN FINANCING ACTIVITIES	(6,300,151)	(10,876,869)	(12,489,003)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	9,494,121	1,611,312	(920,489)
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	10,139,621	8,528,309	9,448,798
CASH AND CASH EQUIVALENTS - END OF YEAR	$ 19,633,742	$ 10,139,621	$ 8,528,309